待处理
入排:排除
图源:待检查
入排置信度 0.98
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.
Gil Yosipovitch, Peter A Lio, David Rosmarin, Esther Serra-Baldrich, Franz J Legat, Marta Casillas, Evangeline Pierce, Zhuqing Liu, Luna Sun, Hany Elmaraghy, Sonja Ständer
Br J Dermatol 190(2) 289-291
入排依据:未发现恶性肿瘤人群证据。
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板